microRNAs become macro players in somatic cell reprogramming

por Onder, Tamer T, Daley, George Q
Publicado 2011

Perspectives on current models of Friedreich’s ataxia

por Kelekçi, Simge, Yıldız, Abdullah Burak, Sevinç, Kenan, Çimen, Deniz Uğurlu, Önder, Tamer
Publicado 2022

NLRP7 plays a functional role in regulating BMP4 signaling during differentiation of patient-derived trophoblasts

por Alici-Garipcan, Aybuke, Özçimen, Burcu, Süder, Ilke, Ülker, Volkan, Önder, Tamer T., Özören, Nesrin
Publicado 2020

In vivo library screening identifies the metabolic enzyme aldolase A as a promoter of metastatic lung colonization

por Tu, Zhenbo, Hou, Shengqi, Zheng, Yurong, Abuduli, Maerjianghan, Onder, Tamer, Intlekofer, Andrew M., Karnoub, Antoine E.
Publicado 2021

Combination of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer

por Süer, Hande, Erus, Suat, Cesur, Ekin E., Yavuz, Ömer, Ağcaoğlu, Orhan, Bulutay, Pınar, Önder, Tamer T., Tanju, Serhan, Dilege, Şükrü
Publicado 2023

The Epithelial-Mesenchymal Transition Factor SNAIL Paradoxically Enhances Reprogramming

por Unternaehrer, Juli J., Zhao, Rui, Kim, Kitai, Cesana, Marcella, Powers, John T., Ratanasirintrawoot, Sutheera, Onder, Tamer, Shibue, Tsukasa, Weinberg, Robert A., Daley, George Q.
Publicado 2014

Epigenetic Reprogramming of Lineage-Committed Human Mammary Epithelial Cells Requires DNMT3A and Loss of DOT1L

por Breindel, Jerrica L., Skibinski, Adam, Sedic, Maja, Wronski-Campos, Ania, Zhou, Wenhui, Keller, Patricia J., Mills, Joslyn, Bradner, James, Onder, Tamer, Kuperwasser, Charlotte
Publicado 2017

Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer

por Saraç, Hilal, Morova, Tunç, Pires, Elisabete, McCullagh, James, Kaplan, Anıl, Cingöz, Ahmet, Bagci-Onder, Tugba, Önder, Tamer, Kawamura, Akane, Lack, Nathan A.
Publicado 2019

Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells

por Güney-Esken, Gülen, Erol, Özgür Doğuş, Pervin, Burcu, Gürhan Sevinç, Gülben, Önder, Tamer, Bilgiç, Elif, Korkusuz, Petek, Günel-Özcan, Ayşen, Uçkan-Çetinkaya, Duygu, Aerts-Kaya, Fatima
Publicado 2021

AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation

por Uğurlu-Çimen, Deniz, Odluyurt, Deniz, Sevinç, Kenan, Özkan-Küçük, Nazlı Ezgi, Özçimen, Burcu, Demirtaş, Deniz, Enüstün, Eray, Aztekin, Can, Philpott, Martin, Oppermann, Udo, Özlü, Nurhan, Önder, Tamer T.
Publicado 2021

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

por Ma, Li, Young, Jennifer, Prabhala, Harsha, Pan, Elizabeth, Mestdagh, Pieter, Muth, Daniel, Teruya-Feldstein, Julie, Reinhardt, Ferenc, Onder, Tamer T., Valastyan, Scott, Westermann, Frank, Speleman, Frank, Vandesompele, Jo, Weinberg, Robert A.
Publicado 2010

Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling

por Akbari, Soheil, Sevinç, Gülben Gürhan, Ersoy, Nevin, Basak, Onur, Kaplan, Kubra, Sevinç, Kenan, Ozel, Erkin, Sengun, Berke, Enustun, Eray, Ozcimen, Burcu, Bagriyanik, Alper, Arslan, Nur, Önder, Tamer Tevfik, Erdal, Esra
Publicado 2019

Chromatin modifying enzymes as modulators of reprogramming

por Onder, Tamer T., Kara, Nergis, Cherry, Anne, Sinha, Amit U., Zhu, Nan, Bernt, Kathrin M., Cahan, Patrick, Mancarci, Ogan. B., Unternaehrer, Juli, Gupta, Piyush B., Lander, Eric S., Armstrong, Scott A., Daley, George Q.
Publicado 2012

KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL

por Kurt, Ibrahim Cagri, Sur, Ilknur, Kaya, Ezgi, Cingoz, Ahmet, Kazancioglu, Selena, Kahya, Zeynep, Toparlak, Omer Duhan, Senbabaoglu, Filiz, Kaya, Zeynep, Ozyerli, Ezgi, Karahüseyinoglu, Sercin, Lack, Nathan A, Gümüs, Zeynep H, Onder, Tamer T, Bagci-Onder, Tugba
Publicado 2017

BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming

por Sevinç, Kenan, Sevinç, Gülben Gürhan, Cavga, Ayşe Derya, Philpott, Martin, Kelekçi, Simge, Can, Hazal, Cribbs, Adam P., Yıldız, Abdullah Burak, Yılmaz, Alperen, Ayar, Enes Sefa, Arabacı, Dilşad H., Dunford, James E., Ata, Deniz, Sigua, Logan H., Qi, Jun, Oppermann, Udo, Onder, Tamer T.
Publicado 2022

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities

por Yedier-Bayram, Ozlem, Gokbayrak, Bengul, Kayabolen, Alisan, Aksu, Ali Cenk, Cavga, Ayse Derya, Cingöz, Ahmet, Kala, Ezgi Yagmur, Karabiyik, Goktug, Günsay, Rauf, Esin, Beril, Morova, Tunc, Uyulur, Fırat, Syed, Hamzah, Philpott, Martin, Cribbs, Adam P., Kung, Sonia H. Y., Lack, Nathan A., Onder, Tamer T., Bagci-Onder, Tugba
Publicado 2022

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival

por Ozyerli-Goknar, Ezgi, Kala, Ezgi Yagmur, Aksu, Ali Cenk, Bulut, Ipek, Cingöz, Ahmet, Nizamuddin, Sheikh, Biniossek, Martin, Seker-Polat, Fidan, Morova, Tunc, Aztekin, Can, Kung, Sonia H. Y., Syed, Hamzah, Tuncbag, Nurcan, Gönen, Mehmet, Philpott, Martin, Cribbs, Adam P., Acilan, Ceyda, Lack, Nathan A., Onder, Tamer T., Timmers, H. T. Marc, Bagci-Onder, Tugba
Publicado 2023

Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis

por Zhang, Yun, Donaher, Joana Liu, Das, Sunny, Li, Xin, Reinhardt, Ferenc, Krall, Jordan A., Lambert, Arthur W., Thiru, Prathapan, Keys, Heather R., Khan, Mehreen, Hofree, Matan, Wilson, Molly M., Yedier-Bayram, Ozlem, Lack, Nathan A., Onder, Tamer T., Bagci-Onder, Tugba, Tyler, Michael, Tirosh, Itay, Regev, Aviv, Lees, Jacqueline A., Weinberg, Robert A.
Publicado 2022